Insider trade

Acadia Pharmaceuticals (ACAD)Officer sold ~$40K

James Kihara, Officer at Acadia Pharmaceuticals, sold ~$40K of Acadia Pharmaceuticals shares.

~$40K
Approx. value · 2,000 sh @ $20.00: 20K
Holds after · shares reported

Traded: May 16, 2025
Filed: May 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Mar 26, 2025Insider · 2 peopleInsiders: 2 sales (~$73K)
Apr 8, 2025Insider · 2 peopleInsiders: 2 sales (~$55K)
May 2, 2025Insider · 2 peopleInsiders: 2 sales (~$70K)
May 16, 2025 · this disclosureInsiderOfficer sold ~$40K of ACAD shares in the open market

What came next

May 16, 2025Insider · 2 peopleInsiders: 2 sales (~$100K)
Jun 4, 2025InsiderDirector sold ~$315K of ACAD shares in the open market
Aug 18, 2025InsiderCFO sold ~$554K of ACAD shares in the open market
Sep 2, 2025InsiderDirector sold ~$42K of ACAD shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Acadia Pharmaceuticals

For Acadia Pharmaceuticals, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACAD page.

Other recent filings by James Kihara, PRINCIPAL ACCOUNTING OFFICER

The full history of James Kihara, PRINCIPAL ACCOUNTING OFFICER is on the profile page.

How this filing works

Other disclosures at Acadia Pharmaceuticals

Everything OQRO holds on this company is on its ACAD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data